CD4+CD28- costimulation-independent T cells in multiple sclerosis

Journal of Clinical Investigation

Volumn 108, Issue 8, 2001, Pages 1185-1194

  Markovic Plese, S ^a   Cortese, I ^a   Wandinger, K P ^a   McFarland, H F ^a   Martin, R ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 12 BETA2 RECEPTOR; INTERLEUKIN 12 RECEPTOR; MYELIN BASIC PROTEIN; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNITY; CELL SPECIFICITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; INFLAMMATION; LYMPHOCYTE COUNT; MEMORY CELL; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL;

ADULT; ANTIGENS, CD; ANTIGENS, CD28; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GENE EXPRESSION; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULINS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, CELL SURFACE; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; RNA, MESSENGER; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 0034773579     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200112516     Document Type: Article

References (42)

1. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
2. Immunological aspects of demyelinating diseases
3. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis
4. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis
5. T cells responsive to myelin basic protein in patients with multiple sclerosis
6. Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis
7. Increased numbers of CCR5-interferon-gamma and tumor necrosis factor-alpha-secreting T lymphocytes in multiple sclerosis patients
8. Adhesion molecule expression on cerebrospinal fluid T lymphocytes: Evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls
9. high expression as a marker
10. Immunology of multiple sclerosis
11. Paradoxical inhibition of T-cell function in response to CTLA-4 blockade; heterogeneity within the human T-cell population
12. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes
13. CTLA-4: A negative regulator of autoimmune disease
14. The B7-CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system
15. New perspectives of CD28-DB7-mediated T cell costimulation
16. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement
17. Following the development of a CD4 T cell response in vivo: From activation to memory formation
18. T cell receptor (TCR)-mediated repertoire selection and loss of TCR vbeca diversity during the initiation of a CD4(+) T cell response in vivo
19. A very high level of crossreactivity is an essential feature of the T-cell receptor
20. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation
21. Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells
22. CD4-CD7-CD28-T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity
23. CD11b+CD28-CD4+ human T cells: Activation requirements and association with HLA-DR alleles
24. Human autoreactive CD4+ T cells from naive CD45RA+ and memory CD45RO- subsets differ with respect to epitope specificity and functional antigen avidity
25. T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death
26. Immunological memory
27. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity
28. Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease
29. Costimulatory molecules in Wegener's granulomatosis (WG): Lack of expression of CD28 and preferential up-regulation of its ligands B7-1(CD80) and B7-2 (CD86) on T cells
30. Aging-related deficiency of CD28 expression in CD4+ T cells is associated with the loss of gene-specific nuclear factor binding activity
31. Developmental regulation of Lck targeting to the CD8 coreceptor controls signaling in naive and memory T cells
32. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cb1-b
33. Cb1-b regulates the CD28 dependence of T-cell activation
34. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes
35. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulator role of CTLA-4
36. Regulation of interleukin (IL)-12 receptor beta2 subunit expression by endogenous IL-12: A critical step in the differentiation of pathogenic autoreactive T cells
37. Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28- T cells from rheumatoid arthritis patients
38. Clonality and longevity of CD4(+)CD28(null) T cells are associated with defects in apoptotic pathways
39. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris
40. Blockade of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitis
41. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis
42. CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease